Unravelling Structure, Localization, and Genetic Crosstalk of KLF3 in Human Breast Cancer
Open Access
- 1 January 2020
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2020 (1)
Abstract
Breast cancer is the most prevailing disease among women. It actually develops from breast tissue and has heterogeneous and complex nature that constitutes multiple tumor quiddities. These features are associated with different histological forms, distinctive biological characteristics, and clinical patterns. The predisposition of breast cancer has been attributed to a number of genetic factors, associated with the worst outcomes. Unfortunately, their behavior with relevance to clinical significance remained poorly understood. So, there is a need to further explore the nature of the disease at the transcriptome level. The focus of this study was to explore the influence of Krüppel‐like factor 3 (KLF3), tumor protein D52 (TPD52), microRNA 124 (miR‐124), and protein kinase C epsilon (PKCε) expression on breast cancer. Moreover, this study was also aimed at predicting the tertiary structure of KLF3 protein. Expression of genes was analyzed through real‐time PCR using the delta cycle threshold method, and statistical significance was calculated by two‐way ANOVA in Graphpad Prism. For the construction of a 3D model, various bioinformatics software programs, Swiss Model and UCSF Chimera, were employed. The expression of KLF3, miR‐124, and PKCε genes was decreased (fold change: 0.076443, 0.06969, and 0.011597, respectively). However, there was 2‐fold increased expression of TPD52 with p value < 0.001 relative to control. Tertiary structure of KLF3 exhibited 80.72% structure conservation with its template KLF4 and was 95.06% structurally favored by a Ramachandran plot. These genes might be predictors of stage, metastasis, receptor, and treatment status and used as new biomarkers for breast cancer diagnosis. However, extensive investigations at the tissue level and in in vivo are required to further strengthen their role as a potential biomarker for prognosis of breast cancer.Keywords
Funding Information
- National University of Sciences and Technology (NRPU 10067)
This publication has 52 references indexed in Scilit:
- Long non‑coding RNA regulation of TRAIL in breast cancer: A tangle of non‑coding threads (Review)Oncology Letters, 2020
- The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing CohortJNCI: Journal of the National Cancer Institute, 2020
- GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targetsBritish Journal of Pharmacology, 2020
- MAGI1, a New Potential Tumor Suppressor Gene in Estrogen Receptor Positive Breast CancerCancers, 2020
- KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in CancerFrontiers in Oncology, 2019
- Identifying breast cancer susceptibility genes – a review of the genetic background in familial breast cancerActa Oncologica, 2019
- MiR‐326/Sp1/KLF3: A novel regulatory axis in lung cancer progressionCell Proliferation, 2018
- Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast CancerJournal of Clinical Oncology, 2016
- A functional family-wide screening of SP/KLF proteins identifies a subset of suppressors of KRAS-mediated cell growthBiochemical Journal, 2011
- Malignant granular cell tumor of the breastJournal of Surgical Oncology, 1992